What after Daniel Callahan’s Insider Sale of Commerce Bancshares, Inc. (CBSH) Stock?; Arrowhead Pharmaceuticals, Inc. (ARWR) Had 3 Bullish Analysts

Among 8 analysts covering Arrowhead Research Corp (NASDAQ:ARWR), 3 have Buy rating, 0 Sell and 5 Hold. Therefore 38% are positive. Arrowhead Research Corp had 23 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has “Buy” rating given on Thursday, May 19 by Chardan Capital Markets. The stock of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) earned “Buy” rating by Cantor Fitzgerald on Friday, August 19. The firm has “Hold” rating by RBC Capital Markets given on Wednesday, August 5. The stock of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has “Hold” rating given on Monday, June 26 by Jefferies. Cantor Fitzgerald maintained it with “Neutral” rating and $5 target in Monday, February 12 report. As per Monday, February 12, the company rating was maintained by B. Riley & Co. On Monday, September 25 the stock rating was maintained by Cantor Fitzgerald with “Hold”. The firm earned “Neutral” rating on Wednesday, November 30 by Chardan Capital Markets. The stock of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) earned “Buy” rating by Chardan Capital Markets on Thursday, November 10. The stock of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has “Hold” rating given on Thursday, August 3 by Jefferies. See Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) latest ratings:

12/02/2018 Broker: FBR Capital Rating: Hold New Target: $4.0 Maintain
12/02/2018 Broker: B. Riley & Co Old Rating: Neutral New Rating: Neutral Old Target: $3 New Target: $4 Maintain
12/02/2018 Broker: Cantor Fitzgerald Old Rating: Hold New Rating: Neutral Old Target: $2 New Target: $5 Maintain
05/01/2018 Broker: B. Riley & Co Rating: Neutral New Target: $3 Initiates Coverage On
04/01/2018 Broker: FBR Capital Rating: Hold New Target: $3.0
27/11/2017 Broker: PiperJaffray Old Rating: Neutral New Rating: Overweight Upgrade
27/11/2017 Broker: Piper Jaffray Rating: Buy New Target: $5.5 Upgrade
25/09/2017 Broker: Cantor Fitzgerald Rating: Hold New Target: $2.0 Maintain
18/09/2017 Broker: William Blair Old Rating: Market Perform New Rating: Outperform Upgrade
14/09/2017 Broker: Piper Jaffray Rating: Hold New Target: $3.0 Maintain

Based on an average stock price per share of $56.9, Daniel Callahan, the Commerce Bancshares Inc’s Exec. Vice President & CCO unloaded 1,090 shares of Commerce Bancshares Inc worth approximately $62,074 U.S Dollars. Daniel is trying to quietly decrease his company’s share, same as he did in the last month. He sold another 2,972 shares worth $174,034 USD. The regulatory filing shows that Daniel Callahan now possess around 0.04% of the Missouri-based company’s total market capitalization

The stock increased 6.01% or $0.31 during the last trading session, reaching $5.47. About 868,219 shares traded. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has declined 67.27% since February 15, 2017 and is downtrending. It has underperformed by 83.97% the S&P500.

Arrowhead Pharmaceuticals, Inc. develops novel drugs to treat intractable diseases in the United States. The company has market cap of $474.73 million. The Company’s pre-clinical stage drug candidates include ARO-HBV to treat chronic hepatitis B virus infection; ARO-AAT to treat liver disease associated with alpha-1 antitrypsin deficiency; ARO-LPA to reduce production of apolipoprotein A; ARO-AMG1, which is developed against an undisclosed genetically validated cardiovascular target; and ARO-F12, a potential treatment for factor 12 mediated diseases, such as hereditary angioedema and thromboembolic disorders. It currently has negative earnings. The firm also develops ARO-HIF2, a drug candidate for the treatment of clear cell renal cell carcinoma.

Since August 30, 2017, it had 0 buys, and 11 selling transactions for $19.69 million activity. On Thursday, October 26 the insider STRANGHOENER V RAYMOND sold $373,700. Another trade for 78,359 shares valued at $4.50M was sold by KEMPER DAVID W. FOSTER SARA E sold $197,261 worth of stock. KIM CHARLES G also sold $405,282 worth of Commerce Bancshares, Inc. (NASDAQ:CBSH) on Monday, January 29. $4.50M worth of Commerce Bancshares, Inc. (NASDAQ:CBSH) was sold by KEMPER JONATHAN M. Another trade for 78,359 shares valued at $4.50M was sold by Kemper John W. PETRIE MICHAEL J had sold 1,709 shares worth $100,428.

Investors sentiment increased to 1.43 in Q3 2017. Its up 0.23, from 1.2 in 2017Q2. It improved, as 10 investors sold Commerce Bancshares, Inc. shares while 73 reduced holdings. 31 funds opened positions while 88 raised stakes. 62.31 million shares or 0.33% less from 62.51 million shares in 2017Q2 were reported. Moreover, Ing Groep Nv has 0.01% invested in Commerce Bancshares, Inc. (NASDAQ:CBSH). Jpmorgan Chase And accumulated 1.09M shares. Thompson Davis And stated it has 0% in Commerce Bancshares, Inc. (NASDAQ:CBSH). Tower Rech Cap Lc (Trc) stated it has 763 shares. Victory Cap Mngmt invested in 33,971 shares. Geode Mngmt Limited Liability Company invested in 798,860 shares. Quantbot Lp holds 331 shares or 0% of its portfolio. Nationwide Fund Advisors invested 0.05% of its portfolio in Commerce Bancshares, Inc. (NASDAQ:CBSH). 13,295 were accumulated by North Star Inv Management Corp. Pinebridge Invs Lp holds 0.06% or 46,470 shares. 57,162 are owned by Bb&T. Los Angeles & Equity Rech has invested 0.03% in Commerce Bancshares, Inc. (NASDAQ:CBSH). Amalgamated Comml Bank holds 0.03% or 17,036 shares in its portfolio. Benjamin F Edwards Com invested in 6,340 shares. The Pennsylvania-based Sei Communication has invested 0.04% in Commerce Bancshares, Inc. (NASDAQ:CBSH).

Commerce Bancshares, Inc. operates as the holding firm for Commerce Bank that provides retail, mortgage banking, corporate, investment, trust, and asset management services and products to individuals and businesses. The company has market cap of $6.28 billion. It operates through three divisions: Consumer, Commercial, and Wealth. It has a 20.38 P/E ratio. The Consumer segment offers various banking services and products, including consumer deposits; consumer loans, such as automobile, motorcycle, marine, tractor/trailer, recreational vehicle, fixed rate and revolving home equity, and other consumer loans; real estate loans; indirect and other consumer financing; personal mortgage banking; and consumer debit and credit bank cards, as well as provides online, mobile, and telephone banking services.

The stock increased 2.38% or $1.37 during the last trading session, reaching $58.89. About 503,639 shares traded or 12.52% up from the average. Commerce Bancshares, Inc. (NASDAQ:CBSH) has risen 19.51% since February 15, 2017 and is uptrending. It has outperformed by 2.81% the S&P500.

Among 8 analysts covering Commerce Bancshares (NASDAQ:CBSH), 0 have Buy rating, 3 Sell and 5 Hold. Therefore 0 are positive. Commerce Bancshares has $62.0 highest and $40 lowest target. $56.17’s average target is -4.62% below currents $58.89 stock price. Commerce Bancshares had 30 analyst reports since October 15, 2015 according to SRatingsIntel. The company was maintained on Wednesday, December 6 by Keefe Bruyette & Woods. Jefferies maintained Commerce Bancshares, Inc. (NASDAQ:CBSH) on Friday, September 15 with “Hold” rating. The firm has “Underperform” rating given on Thursday, August 10 by Raymond James. Keefe Bruyette & Woods maintained it with “Sell” rating and $49.0 target in Tuesday, October 3 report. As per Friday, June 9, the company rating was maintained by Jefferies. The rating was maintained by Keefe Bruyette & Woods on Monday, August 14 with “Sell”. As per Friday, January 6, the company rating was initiated by Wells Fargo. The company was maintained on Friday, August 11 by Jefferies. The firm earned “Sell” rating on Thursday, January 18 by Keefe Bruyette & Woods. The firm has “Hold” rating by Jefferies given on Thursday, October 15.